Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer

被引:19
作者
Ferroni, Patrizia [1 ]
Riondino, Silvia [1 ]
Portarena, Ilaria [2 ]
Formica, Vincenzo [2 ]
La Farina, Francesca [1 ]
Martini, Francesca [1 ]
Massimiani, Gioia [2 ]
Palmirotta, Raffaele [1 ]
Guadagni, Fiorella [1 ]
Roselli, Mario [2 ]
机构
[1] IRCCS San Raffaele Pisana, Dept Lab Med & Adv Biotechnol, I-00163 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Internal Med, Tor Vergata Clin Ctr, Rome, Italy
关键词
Metastatic colorectal cancer; Activated protein C; Tumor necrosis factor alpha; Venous thromboembolism; VENOUS THROMBOEMBOLISM; CARCINOEMBRYONIC ANTIGEN; TNF-ALPHA; INFLAMMATION; THROMBOSIS; CYTOKINES; CHEMOTHERAPY; LEIDEN; BLOOD; RISK;
D O I
10.1007/s00384-012-1493-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose The purpose of this study was to investigate the possible association between tumor necrosis factor-alpha (TNF-alpha) levels and defects in the activated protein C (APC) system as a determinant of venous thromboembolism (VTE) in metastatic colorectal cancer patients (mCRC) undergoing chemotherapy. Methods TNF-alpha levels (measured by immunoassay) and abnormalities in the APC system [evaluated by an APC-dependent thrombin generation assay (ThromboPath-ThP)] were evaluated in 45 mCRC patients undergoing chemotherapy. VTE events were recorded during follow-up. Results TNF-alpha levels were increased (p < 0.01), and APC functionality was decreased (p < 0.0001) in mCRC patients compared to age- and sex-matched controls. An inverse correlation was observed between TNF-alpha and APC impairment in mCRC (p < 0.0001). TNF-alpha was confirmed as an independent predictor (p = 0.007) for APC abnormalities at multivariate regression analysis. Nine (20 %) of 45 mCRC patients experienced VTE during chemotherapy. Bayesian analysis of combined ThP/TNF-alpha showed a positive predictive value of 0.67 in predicting VTE (p = 0.01). Cox proportional hazards survival analysis confirmed the predictive value of combined ThP/TNF-alpha determination in VTE risk assessment of mCRC patients (either negative vs. both positive: HR = 0.02; p = 0.001), and Kaplan-Meier analysis demonstrated that mCRC patients with either negative TNF-alpha or ThP values prior to chemotherapy were less likely to experience VTE (13 %) than patients with abnormalities of both markers (67 %, p = 0.002). Conclusions These results suggest that the host inflammatory response to cancer cells and/or tumor-derived cytokines could be responsible for an impairment of the APC system and a switch toward a pro-thrombotic state, which might predispose to the occurrence of VTE in mCRC patients undergoing chemotherapy.
引用
收藏
页码:1561 / 1567
页数:7
相关论文
共 50 条
[31]   Association between increased C-reactive protein and cardiovascular disease among patients with rectal cancer [J].
Qiao, Huimin ;
Wang, Changxin ;
Yang, Chunhong ;
Lei, Lei ;
Chen, Yijing ;
Luo, Yun ;
Zeng, Xiangfu ;
Guo, You .
FRONTIERS IN ONCOLOGY, 2023, 13
[32]   Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma [J].
Chen, Ling ;
Yang, Xigui ;
Yang, Xiangshan ;
Fan, Kaixi ;
Xiao, Ping ;
Zhang, Jing ;
Wang, Xiuwen .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (01) :238-244
[33]   Serum and urinary levels of tumor necrosis factor-alpha and interferon-gamma in diabetic nephropathy patients: a systematic review [J].
Flake, Chastene Christopher ;
Aguas, Imoan Shallom ;
Policarpio, Archie ;
Ysais, Angelanna ;
Tiongco, Raphael Enrique ;
Navarro, Annalyn .
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (04) :644-651
[34]   Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease [J].
Ágnes Vatay ;
László Bene ;
Ágota Kovács ;
Zoltán Prohászka ;
Csaba Szalai ;
László Romics ;
Béla Fekete ;
István Karádi ;
George Füst .
Immunogenetics, 2003, 55 :247-252
[35]   Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease [J].
Vatay, A ;
Bene, L ;
Kovács, A ;
Prohászka, Z ;
Szalai, C ;
Romics, L ;
Fekete, B ;
Karádi, I ;
Füst, G .
IMMUNOGENETICS, 2003, 55 (04) :247-252
[36]   Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus [J].
Nojima, Junzo ;
Iwatani, Yoshinori ;
Ichihara, Kiyoshi ;
Tsuneoka, Hidehiro ;
Ishikawa, Toshizo ;
Yanagihara, Masashi ;
Takano, Toru ;
Hidaka, Yoh .
THROMBOSIS RESEARCH, 2009, 124 (01) :127-131
[37]   Acquired activated protein C resistance in myeloma patients with venous thromboembolic events [J].
Deitcher, SR ;
Choueiri, T ;
Srkalovic, G ;
Hussein, MA .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (05) :959-959
[38]   Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer [J].
Garrity-Park, Megan M. ;
Loftus, Edward V., Jr. ;
Bryant, Sandra C. ;
Sandborn, William J. ;
Smyrk, Thomas C. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (02) :407-415
[39]   Serum and Urinary Levels of Tumor Necrosis Factor-Alpha in Renal Transplant Patients [J].
Ciftci, Hayriye Senturk ;
Demir, Erol ;
Karadeniz, Meltem Savran ;
Tefik, Tzevat ;
Yazici, Halil ;
Nane, Ismet ;
Oguz, Fatma Savran ;
Aydin, Filiz ;
Turkmen, Aydin .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (06) :671-675
[40]   Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression [J].
Bizik, Gustav ;
Bob, Petr ;
Raboch, Jiri ;
Pavlat, Josef ;
Uhrova, Jana ;
Benakova, Hana ;
Zima, Tomas .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 :675-679